Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2380417 | 0.78 | ALDH1A1 (0.42) | LMNAALDH1A1SMN1; SMN2POLBMAPT | |
| SCHEMBL17767809 | 0.78 | SMN1; SMN2 (0.50) | HPGDALDH1A1SMN1; SMN2HTTHDAC3 | |
| SCHEMBL20999873 | 0.78 | SMN1; SMN2 (0.50) | HPGDALDH1A1SMN1; SMN2HTTHDAC3 | |
| SCHEMBL17767812 | 0.78 | SMN1; SMN2 (0.50) | HPGDALDH1A1SMN1; SMN2HTTHDAC3 | |
| SCHEMBL17168743 | 0.78 | SMN1; SMN2 (0.50) | HPGDALDH1A1SMN1; SMN2HTTHDAC3 | |
| SCHEMBL26382038 | 0.78 | SMN1; SMN2 (0.50) | HPGDALDH1A1SMN1; SMN2HTTHDAC3 | |
| SCHEMBL6193414 | 0.78 | MGLL (0.44) | ALDH1A1MAPT | |
| SCHEMBL15326722 | 0.77 | TP53 (0.42) | LMNAHPGDALDH1A1SMN1; SMN2POLB | |
| SCHEMBL21117960 | 0.77 | SMN1; SMN2 (0.49) | LMNAHPGDALDH1A1SMN1; SMN2HTT | |
| SCHEMBL17767844 | 0.76 | RECQL (0.47) | LMNAHPGDALDH1A1SMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250380973-A1 | COMPLIANT BONE PLATE FOR FRACTURE FIXATION | PENN STATE RES FOUND (US) | 2025-12-18 | — | — | US | claimed |
| EP-4618868-A1 | COMPLIANT BONE PLATE FOR FRACTURE FIXATION | The Penn State Research Foundation (US) | 2025-09-24 | — | — | EP | claimed |
| CN-113765853-B | Encryption control overhead transmission method and device in optical transport network | 中兴通讯股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119180782-A | Control cable defect detection method based on improved YOLOv algorithm | 广东电网有限责任公司东莞供电局 | 2024-12-24 | — | — | CN | claimed |
| WO-2024107980-A1 | COMPLIANT BONE PLATE FOR FRACTURE FIXATION | THE PENN STATE RESEARCH FOUNDATION (US) | 2024-05-23 | — | — | WO | claimed |
| CN-117934305-A | Medical image fusion method based on shared multi-dimensional component tensor dictionary learning | 南京邮电大学 | 2024-04-26 | — | — | CN | claimed |
| EP-3486678-B1 | MULTI-SIGNAL INSTANTANEOUS FREQUENCY MEASUREMENT SYSTEM | ROHDE & SCHWARZ (DE) | 2023-08-30 | — | — | EP | claimed |
| CN-122071433-A | Imidazole derivative, intermediate, preparation method and application thereof | 江苏恩华药业股份有限公司 | 2026-05-22 | — | — | CN | disclosed |
| EP-4740013-A1 | LINKING RECEPTOR OCCUPANCY TO EFFICACY OF CXCR4 ANTAGONISTS | AdAlta Limited (AU) | 2026-05-13 | — | — | EP | disclosed |
| EP-4729516-A1 | SUBSTITUTED IMIDAZOLE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD THEREFOR AND USE THEREOF | Jiangsu NHWA Pharmaceutical Co., Ltd (CN) | 2026-04-22 | — | — | EP | disclosed |
| US-20260105018-A1 | ADAPTING OPEN COMPUTE PROJECT TO SUPPORT SENSOR I/O STANDARDS | ONE STOP SYSTEMS INC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4726560-A1 | ADAPTING OPEN COMPUTE PROJECT TO SUPPORT SENSOR I/O STANDARDS | One Stop Systems, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4714499-A2 | POLYAMIDE COMPOUNDS, METHOD FOR PREPARING SAME, AND MEDICAL USE THEREOF | Jiangsu NHWA Pharmaceutical Co., Ltd (CN) | 2026-03-25 | — | — | EP | disclosed |
| CN-114258303-A | Prevention of highly pathogenic viral infections using topical application of povidone-iodine to mucous membranes | 法尔布里克制药有限公司 | 2022-03-29 | — | — | CN | disclosed |
| US-20220088067-A1 | PREVENTION OF INFECTION BY HIGHLY PATHOGENIC VIRUSES USING TOPICAL APPLICATION OF POVIDONE-IODINE ON MUCOUS MEMBRANES | FIREBRICK PHARMA LIMITED (AU) | 2022-03-24 | — | — | US | disclosed |
| WO-2022037852-A1 | DISTRIBUTED END-TO-END MONITORING IN INDUSTRY AND CONTROL NETWORKS | SIEMENS AKTIENGESELLSCHAFT (DE) | 2022-02-24 | — | — | WO | disclosed |
| EP-3958510-A1 | DISTRIBUTED END-TO-END MONITORING IN INDUSTRY AND CONTROL NETWORKS | Siemens Aktiengesellschaft (DE) | 2022-02-23 | — | — | EP | disclosed |
| US-11246887-B2 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes | FIREBRICK PHARMA LIMITED (AU) | 2022-02-15 | — | — | US | disclosed |
| WO-2022020886-A1 | A DETECTION METHOD FOR VIRAL REPLICATION | Microbio Pty Ltd (AU) | 2022-02-03 | — | — | WO | disclosed |
| US-11232812-B1 | Air-bearing surface (ABS) design with side flow blocker for mitigating lube and hydrocarbon accumulation in hard disk drives (HDD) | SAE MAGNETICS (H.K.) LTD. (HK) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260105018-A1 | ADAPTING OPEN COMPUTE PROJECT TO SUPPORT SENSOR I/O STANDARDS | OSTC, ALPI, IPO11 | LMNA 1926/4885HPGD 3711/4885ALDH1A1 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.